(Q30447470)

21 June 2017

1 reference

title

Estrogen agonists/antagonists in combination with estrogen for prevention and treatment of menopause-associated signs and symptoms (English)

1 reference

21 June 2017

2

JoAnn V Pinkerton

1 reference

21 June 2017

Dale W Stovall

1

1 reference

21 June 2017

publication date

1 May 2008

1 reference

21 June 2017

1 reference

21 June 2017

volume

4

1 reference

21 June 2017

issue

3

1 reference

21 June 2017

page(s)

257-268

1 reference

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

21 June 2017

cites work

1 reference

https://api.crossref.org/works/10.2217%2F17455057.4.3.257

Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.4.3.257

Aromatase--a brief overview

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.4.3.257

Insights into the molecular biology of the estrogen receptor define novel therapeutic targets for breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.4.3.257

Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.4.3.257

Coregulator function: a key to understanding tissue specificity of selective receptor modulators

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.4.3.257

Caveolae, estrogen and nitric oxide

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.4.3.257

A review of selective estrogen receptor modulators and national surgical adjuvant breast and bowel project clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.4.3.257

Bazedoxifene and bazedoxifene combined with conjugated estrogens for the management of postmenopausal osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.4.3.257

Optimal sequence of hormonotherapy in advanced breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.4.3.257

Influence of hormone replacement therapy on tamoxifen-induced vasomotor symptoms.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.4.3.257

The Effect of Raloxifene on Risk of Breast Cancer in Postmenopausal Women

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.4.3.257

Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.4.3.257

Effects of raloxifene on cardiovascular events and breast cancer in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.4.3.257

Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.4.3.257

The effects of combined raloxifene and oral estrogen on vasomotor symptoms and endometrial safety

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.4.3.257

Bazedoxifene acetate: a selective estrogen receptor modulator with improved selectivity

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.4.3.257

Effects of bazedoxifene on BMD and bone turnover in postmenopausal women: 2-yr results of a randomized, double-blind, placebo-, and active-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.4.3.257

Endometrial effects of bazedoxifene acetate, a novel selective estrogen receptor modulator, in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.4.3.257

21 January 2018

Identifiers

DOI

10.2217/17455057.4.3.257

1 reference

21 June 2017

1 reference